No randomized trials have been conducted to demonstrate that a particular phenotype or MC mediator level is associated with a specific treatment response
A recent study has shown that, in ARPE-19 cells and DR mouse models, it was found that TERF1 Interacting Nuclear Factor 2 (TIN2) inhibits mitophagy by promoting mTOR pathway activity, thereby inducing the aging of RPE cells under high glucose conditions
Studies have shown, however, that taking L-carnitine both orally as well as intravenously can both prevent and treat low levels of L-carnitine and associated symptoms such as anemia and inflammation
Peptides like BPC-157 and TB-500 are not FDA-approved medications, and safety depends heavily on proper medical screening, dosing, and sourcing
Total protein: ~22g
Need repeated scheduled signaling windows: Consider a divided schedule within the common range